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The element selenium, discovered by Berzelius in the early nineteenth century, has had
an extremely widespread use in industry. Some of the processes in which selenium plays a
part are the coloring of paints and inks, alloying of metals, vulcanization of rubber, and
fireproofing of photoelectrical devices. Its most recent use has been in medicine as a sulfide
suspension to be applied topically to the scalp as a new treatment for seborrheic dermatitis.
Because of its proximity to arsenic in the periodic table, selenium has long had the repu-
tation for having similar properties and similar toxicity. It is the purpose of this paper to
review the toxicity of selenium as well as its mode of action. The toxicity of the selenium
suspension is compared to the suspending vehicle alone by tissue culture methods.
Interest in the toxicity of selenium for animals was first aroused when Robinson (17)
discovered that the disease of cattle known as blind staggers or alkali disease was caused
by the ingestion of selenium in plants upon which they grazed which were grown in a highly
seleniferous soil. The signs of selenium poisoning in livestock are loss of weight, emaciation,
and loss of hair. The hooves slough and the animals lose control of their voluntary muscles.
This results in a staggering gait; hence the name "blind staggers." After it was found that
plants grown in the Great Plains region, including South Dakota, Wyoming, and Nebraska,
contained a significant quantity of selenium and that animals ingesting these plants de-
veloped toxic effects, a concerted effort was made to see whether or not the humans living
in those areas might not also be affected.
Smith, Franke and Westf all (25) surveyed 111 families and found no symptoms which
they felt were indicative of selenium intoxication. However, in a series of 100 cases with in-
creased selenium in the serum nd increased urinary excretion, Smith and Westf all (26)
reported 31% possible gastric or intestinal dysfunction and 33% icterus or a past history of
jaundice. Lemley and Merryman (8) reported 30 cases of what they considered to be selenium
poisoning in humans. In some cases they found the serum selenium levels to be as high as
55 to 600 parts per billion. The symptoms found consisted of depression, dizziness, and
clouding of the sensorium. Several people complained of lassitude within three to four hours
after awaking in the morning. Intestinal symptoms were frequently present. These consisted
of burning epigastric pain, gas and diarrhea. Dermatitis was also seen as a perifollicular,
pustular eruption with consecutive brownish, bronzed pigmentation distributed particu-
larly over the hairy surface of the forearms and anterior of the thighs.
Other evidence of toxicity to selenium has been reported as found in industry. Buchan
(1) in a review of the literature cites cases with such other symptoms as nasopharyngeal and
bronchial irritation, also a persisting garlic-like odor of breath. In this article he cites
Dudley (2), who reported eighteen copper refinery workers who had gastric symptoms, in-
creased nervousness and a garlic-like odor of the breath after contact of selenium contain-
ing compounds with the skin. One case of a contact dermatitis of the lips following the use
of a selenium red lipstick is also reported.
Pringle (16) mentions purpuric spots occurring after the splashing of selenous acid on the
forearms. Another patient had a weeping, papulopustular eruption on the flexor surfaces
of the arms after contact with selenium fumes. Two girls developed paronychia after con-
tact with dry selenium dioxide.
It has been found that the toxicity of selenium is unique in that selenium from different
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sources is not equally toxic. Selenate is more harmful than the selenite, which in turn is
more noxious than selenide. Metallic selenium is least toxic of all. In addition Moxon (11)
has found that the method of administration is important. Orally the product is much less
toxic for mice than by subcutaneous injection. The response will differ in different species of
animal being tested to contact with selenium compounds, and there is even a difference in
the susceptibility of different tissues. Age of the test animal must also be considered since
the adult individual is less readily affected than the young.
The mode of action of selenium in the body is as much in dispute as the toxicity. There
are several theories for which there seems to be some justification by proof. Most authors,
including Painter (14), accept the theory that selenium oxidizes sulfhydryl compounds
forming the disulfide and an unstable RS—Se----RS complex. This may inhibit certain en-
zymatic reactions which depend on reversible sulfhydryl disulfide changes.
Hopkins and Morgan (6) have shown that the succinic dehydrogenase of the blood is de-
creased in rats fed Na2SeO, and believe the toxic effect may be on this basis. McConnel and
Cooper (9) hypothesize that selenium displaces sulfur in various amino-acids and so makes
them unavailable for use.
Even though the exact mode of action and toxicity of selenium is still in dispute, Slinger
(24) investigated a 23'% suspension of selenium disulfide under the trade name of Selsun
Suspension. He was unable to demonstrate any absorption as indicated by urinary excretion
even when the shampoo was used daily for as long as 19 days on eczematous areas of atopic
dermatitis. In addition he was unable to demonstrate any toxicity or sensitivity to the
Selsun or to any of its individual components. Both Slinger (24) and Slepyan (23) reported
control of symptoms in more than 80% of cases of scaling dermatitis of the scalp.
Because of the efficacy of this product and its increasingly widespread use, it was deemed
advisable to test its toxicity by tissue culture methods which had shown close correlation
to toxicity of antibiotics (4). Selenium had been previously studied in tissue culture by
various authors. A. H. Roffo in 1925 (19) found that potassium selenate inhibited cellu-
lar division in dilutions of less than 1:10,000 in normal tissue and in dilutions of 1:100,000
in neoplastic tissue. In 1939 (18) he reported a slight inhibitory effect of metallic selenium
on sarcoma fibroblasts. Nita (13), working on fibroblastic outgrowths, found the selenium
in low concentrations increased growth but with increase in concentration inhibited growth.
Ruffilli (22) found that cultures of chick myocardium were inhibited by 0.01% colloidal
selenium, 0.001% selinuria and by 0.0033% selenium dioxide.
METHOD
From the previous work which had been done on selenium compounds, we
had some idea where the toxicity would lie; however, no work had actually ever
been done using selenium disulfide. Although we wanted to work primarily with
human tissues, a preliminary titration was set up using 19-day-old chick spleen
to determine the approximate least injurious dose (LID), the smallest quantity
to show the first effects of injury, and the minimal inhibitory dose (MID),
the smallest quantity to produce complete inhibition of growth. In addition, a
duplicate titration was run on the vehicle alone containing all the essential
ingredients except the selenium disulfide.
The method used was similar to that of Everett (4), in which the essential
steps are as follows:
1. The spleens were removed aseptically from 19-day-old chick embryos and
divided into cubes of approximately 1 mm. in each dimension.
2. Each fragment was then embedded in a clot composed of one drop of
embryonic extract juice (EEJ) and one drop of cockerel plasma on a sterile
1 square cover slip.
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TABLE I
Preliminary titration using 19 day old chick spleen
Control 1:1,000,000 1:100,000 1:10,000 1:1000 1:100 1:10
Vehicle
4+
3+
2+
1+
No growth
0
37.5%
25.0%
37.5%
0
0
0
0
87.5%
12.5%
0
0
0
12.5%
75.0%
12.5%
0
0
0
37.5%
25.0%
37.5%
0
0
0
0
25.0%
37.5%
37.5%
0
0
0
0
0
100%
0
0
0
0
0
0
100%
Selsun
4+
3+
2+
1+
No growth
0
0
75%
25%
0
0
0
0
75%
25%
0
0
0
0
60%
40%
0
0
0
0
0
20%
80%
0
0
0
0
0
100%
0
0
0
0
0
100%
3. The selenium disuifide suspension or vehicle had been added to the em-
bryonic extract in dilutions ranging from 1:1,000,000 to 1:10 with appro-
priate drug free controls.
4. The cover slip was inverted on a medium sized hanging drop slide after
the clot had set and sealed with paraffin wax and incubated at 370 C. for
24 hours.
TABLE II
Titration using human skin
Control 1:100,000 1:10,000 1:1000 1:100
Vehicle
4+
3+
2+
1+
No growth
0
0
70%
30%
0
0
0
0
65%
5%
30%
0
0
0
0
20%
80%
0
0
0
0
0
40%
60%
0
0
0
0
0
100%
4+
3+
2+
1+
No growth
Selsun
0
0
70%
30%
0
0
0
0
0
80%
20%
0
0
0
0
0
20%
80%
0
0
0
0
100%
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TABLE III
Comparison of MID and LID
No. of Culture LID MID
Chick Spleen
Control
Vehicle
Selsun
30
50
100
1:1000
1:1000
1:10
1:10
Human Skin
Control
Vehicle
Selsun
40
110
120
1:10,000
1:10,000
1:100
1:100
At the end of 24 hours, the chick spleen had reached its maximum outgrowth,
and the cultures were read on a microscope using a 16 mm. objective and a
x 10 ocular. Fifty cultures using the vehicle and 100 cultures using Selsun were
set up. These were graded as 1+, 2+, 3+, or 4+ depending on whether the
outgrowth extended , 3, or entirely across the field respectively. They
were graded as if there was some outgrowth but less than /4 of the field was
covered.
The experiment was then repeated using human skin (table II). This was cut
by means of a microtome on a remnant of skin left over after a grafting proce-
dure. The method used was similar to that used for the chick spleen with the
following exceptions:
1. The skin was cut into squares approximately 2 mm. x 2 mm.
2. One gamma/cc. of neomycin sulfate was added to the plasma as a bacterial
inhibitor.
3. After the clot had set, four drops of ascitic fluid from a patient with abdom-
inal carcinomatosis was added as nutrient material.
4. Cultures were examined every day or two until the seventh day, at which
time maximum outgrowth was obtained.
One hundred and ten cultures using the vehicle and 120 cultures using Selsun
were set up. Representative sections were fixed in methyl alcohol and stained
according to the technic of Jacobson for permanent records.
Some difficulty was encountered in reading the more concentrated dilutions
in that the material being a suspension tended to obscure the cell outlines; how-
ever, by focusing up and down with the objective it was found that the particles
of the suspension were at a slightly different level than the cells of the outgrowth
in most cases and so probably did not give rise to a significant error.
DISCUSSION
The toxicity of selenium disulfide suspension on chick spleen growing out in
tissue culture is of the same magnitude as the toxicity on human skin when tested
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in the manner described. In this way an accurate estimate of the best range of
dilutions to use was determined within 24 hours by using the faster growing,
more easily cultured chick spleen as a preliminary titration.
According to our interpretation of the experimental data, there is no appre-
ciable difference in the toxicity of Selsun as compared to the suspending vehicle
alone. It must be remembered, however, that this method would determine only
toxicity to the skin or primary irritation capacity. This study does not attempt
to evaluate any allergic response or such toxic reactions which might occur in
other organs if selenium disulfide penetrates the skin.
Some of the effects seen might be due to the other ingredients in the formula,
which is as follows:
%
Selenium disulfide 2.5
A Nacconol (surface active agent) 17.0
Inert and stabilizing ingredients 5.2
Water qs. ad 100.0
In our clinical experience the sensitization index must be very low in any event
since we have not encountered a single case of sensitivity which could be directly
related to selenium disulfide in four years of frequent use in clinic and private
practice. To date we have been unable to find a single case of sensitivity reported
in the literature.
SUMMARY
1. The uses of selenium in industry and medicine, which are more extensive
than generally considered, have been reviewed.
2. The toxicity of selenium-containing compounds for animals and humans
with relation to selenium disulfide suspension as a therapeutic agent for sebor-
rheic dermatitis has been discussed.
3. An experiment using tissue culture technics first on chick spleen, then on
human skin, to show that 2.5 % selenium disulfide suspension is no more toxic
than the vehicle alone has been described.
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